Gary Walsh

7.9k total citations · 5 hit papers
81 papers, 5.5k citations indexed

About

Gary Walsh is a scholar working on Molecular Biology, Biotechnology and Genetics. According to data from OpenAlex, Gary Walsh has authored 81 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 23 papers in Biotechnology and 14 papers in Genetics. Recurrent topics in Gary Walsh's work include Enzyme Production and Characterization (18 papers), Biosimilars and Bioanalytical Methods (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Gary Walsh is often cited by papers focused on Enzyme Production and Characterization (18 papers), Biosimilars and Bioanalytical Methods (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Gary Walsh collaborates with scholars based in Ireland, United States and United Kingdom. Gary Walsh's co-authors include Roy Jefferis, Anne Casey, Michael P. Ryan, Shane O’Connell, Denis R. Headon, Ronan F. Power, Gerry F. Killeen, B V Palmer, J A McKinna and W P Greening and has published in prestigious journals such as Nature Biotechnology, Analytical Biochemistry and Bioresource Technology.

In The Last Decade

Gary Walsh

79 papers receiving 5.3k citations

Hit Papers

Biopharmaceutical benchmarks 2014 2006 2026 2012 2019 2014 2018 2006 2010 2022 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biopharmaceutical benchmarks 2014
    2014 774 citations Gary Walsh Nature Biotechnology profile →
  2. Biopharmaceutical benchmarks 2018
    2018 709 citations Gary Walsh Nature Biotechnology profile →
  3. Post-translational modifications in the context of therapeutic proteins
    2006 708 citations Gary Walsh et al. Nature Biotechnology profile →
  4. Biopharmaceutical benchmarks 2010
    2010 589 citations Gary Walsh Nature Biotechnology profile →
  5. Biopharmaceutical benchmarks 2022
    2022 267 citations Gary Walsh et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Walsh Ireland 30 4.1k 1.3k 939 693 572 81 5.5k
Willem P.C. Stemmer United States 30 5.8k 1.4× 912 0.7× 919 1.0× 838 1.2× 1.3k 2.2× 49 7.0k
Wei‐Chiang Shen United States 43 4.5k 1.1× 752 0.6× 478 0.5× 469 0.7× 535 0.9× 131 6.8k
Hai Yu United States 53 6.3k 1.5× 830 0.6× 721 0.8× 289 0.4× 491 0.9× 277 8.8k
Nicole Borth Austria 40 3.8k 0.9× 621 0.5× 467 0.5× 492 0.7× 903 1.6× 148 4.5k
Ursula Rinas Germany 45 4.5k 1.1× 445 0.3× 913 1.0× 987 1.4× 1.1k 1.9× 151 5.9k
Joachim Jose Germany 37 3.1k 0.7× 1.1k 0.8× 429 0.5× 837 1.2× 548 1.0× 252 5.0k
Stephan A. Sieber Germany 50 4.9k 1.2× 357 0.3× 517 0.6× 363 0.5× 479 0.8× 236 7.8k
Lai‐Xi Wang United States 52 6.6k 1.6× 2.6k 2.0× 1.2k 1.3× 224 0.3× 177 0.3× 215 8.4k
Paul Kosma Austria 47 3.0k 0.7× 344 0.3× 299 0.3× 1.5k 2.1× 454 0.8× 291 7.6k
Manuel Fuentes Spain 38 4.0k 1.0× 492 0.4× 601 0.6× 1.0k 1.5× 100 0.2× 146 5.1k

Countries citing papers authored by Gary Walsh

Since Specialization
Citations

This map shows the geographic impact of Gary Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Walsh more than expected).

Fields of papers citing papers by Gary Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Walsh. The network helps show where Gary Walsh may publish in the future.

Co-authorship network of co-authors of Gary Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Walsh. A scholar is included among the top collaborators of Gary Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Walsh. Gary Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Gary, et al.. (2024). Truncation of a novel C‐terminal domain of a β‐glucanase improves its thermal stability and specific activity. Biotechnology Journal. 19(8). e2400245–e2400245. 1 indexed citations
2.
Fitzpatrick, David A., et al.. (2023). Recombinant production, characterization and industrial application testing of a novel acidic exo/endo-chitinase from Rasamsonia emersonii. Extremophiles. 27(2). 10–10. 5 indexed citations
3.
Walsh, Gary, et al.. (2018). Expression and characterisation of a thermophilic endo-1,4-β-glucanase from Sulfolobus shibatae of potential industrial application. Molecular Biology Reports. 45(6). 2201–2211. 22 indexed citations
4.
Walsh, Gary. (2014). Biopharmaceutical benchmarks 2014. Nature Biotechnology. 32(10). 992–1000. 774 indexed citations breakdown →
5.
Ryan, Michael P. & Gary Walsh. (2012). Veterinary-based biopharmaceuticals. Trends in biotechnology. 30(12). 615–620. 3 indexed citations
6.
Walsh, Gary. (2010). The importance of and an approach to comprehensive reflective practice. Biochemistry and Molecular Biology Education. 38(1). 1–3. 3 indexed citations
7.
Turner, Kevin M., et al.. (2010). Stabilization of a supplemental digestive enzyme by post-translational engineering using chemically-activated polyethylene glycol. Biotechnology Letters. 33(3). 617–621. 10 indexed citations
8.
Hu, Xuejun, Sylvain Robin, Shane O’Connell, Gary Walsh, & J. Gerard Wall. (2010). Engineering of a fungal β-galactosidase to remove product inhibition by galactose. Applied Microbiology and Biotechnology. 87(5). 1773–1782. 42 indexed citations
9.
Walsh, Gary. (2010). Biopharmaceutical benchmarks 2010. Nature Biotechnology. 28(9). 917–924. 589 indexed citations breakdown →
10.
Walsh, Gary. (2010). Post-translational modifications of protein biopharmaceuticals. Drug Discovery Today. 15(17-18). 773–780. 172 indexed citations
11.
Walsh, Gary. (2007). Protein engineering: Case studies of commercialized engineered products. Biochemistry and Molecular Biology Education. 35(1). 2–8. 7 indexed citations
12.
Walsh, Gary. (2005). Interoperability of United States and Canadian Armed Forces. Duke journal of comparative & international law. 15(2). 315–331. 1 indexed citations
13.
Mahan, Scott, et al.. (2004). Collaborative Design for Automated DNA Storage That Allows for Rapid, Accurate, Large-Scale Studies. Assay and Drug Development Technologies. 2(6). 683–689. 9 indexed citations
14.
Walsh, Gary. (2004). Therapeutic insulins and their large-scale manufacture. Applied Microbiology and Biotechnology. 67(2). 151–159. 96 indexed citations
15.
Casey, Anne, et al.. (2004). A phytase enzyme‐based biochemistry practical particularly suited to students undertaking courses in biotechnology and environmental science. Biochemistry and Molecular Biology Education. 32(5). 336–340. 18 indexed citations
16.
Nilson, R. H., et al.. (2003). Analytical models for high-temperature corrosion of silica refractories in glass-melting furnaces. TIB Repositorium. 1 indexed citations
17.
Walsh, Gary. (1995). Nervous Excitement over Neurotrophic Factors. Nature Biotechnology. 13(11). 1168–1170. 9 indexed citations
18.
Walsh, Gary, Richard Murphy, Gerry F. Killeen, Denis R. Headon, & Ronan F. Power. (1995). Technical note: detection and quantification of supplemental fungal β-glucanase activity in animal feed. Journal of Animal Science. 73(4). 1074–1076. 51 indexed citations
19.
Walsh, Gary. (1993). Enzymes in the animal-feed industry. Trends in biotechnology. 11(10). 424–430. 83 indexed citations
20.
Palmer, B V, Gary Walsh, J A McKinna, & W P Greening. (1980). Adjuvant chemotherapy for breast cancer: side effects and quality of life.. BMJ. 281(6255). 1594–1597. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willem P.C. Stemmer Breakdown of academic impact, for papers by Wei‐Chiang Shen Breakdown of academic impact, for papers by Hai Yu Breakdown of academic impact, for papers by Nicole Borth Breakdown of academic impact, for papers by Ursula Rinas Breakdown of academic impact, for papers by Joachim Jose Breakdown of academic impact, for papers by Stephan A. Sieber Breakdown of academic impact, for papers by Lai‐Xi Wang Breakdown of academic impact, for papers by Paul Kosma Breakdown of academic impact, for papers by Manuel Fuentes
Rankless by CCL
2026